Abstract
There is a significant opportunity to improve cardiovascular disease (CVD) outcomes in lung cancer screening cohorts with a low-cost, noninvasive assessment of CVD risk, alongside existing assessments https://bit.ly/3a6Ha41
Footnotes
Conflict of interest: A. Guariglia has nothing to disclose.
Conflict of interest: I.J. Davies has nothing to disclose.
Conflict of interest: N.I. Kanellakis has nothing to disclose.
- Received July 22, 2020.
- Accepted August 5, 2020.
- Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/
Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.